Dark

QNCX
Quince Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Feb 10, 2026 3:59:56 PM EST

0.5300USD+305.692%(+0.4000)1,486,127,690

0.5500Bid 3.99Ask 3.4400Spread

Pre-market

Feb 10, 2026 9:28:30 AM EST

0.2759USD+112.231%(+0.1459)65,135,368

After-hours

Feb 10, 2026 4:47:30 PM EST

0.4856USD-7.926%(-0.0418)32,585,568

OverviewOptionsHistoricalExchangesShortsTrends

open chart

Market Cap

29.40M

Industry

Biotechnology

Next Earnings

Mar 23, 2026 (40d)

QNCX Stats

Avg. Vol. 10 Day

13,224,237

Avg. Vol. 30 Day

5,080,173

Employees

Market Cap

29,399,771

Shares Out.

55,681,490

On/Off Exchange

41%/59%

6 Month Beta

2.67

1 Year Beta

0.41

2 Year Beta

0.17

3 Year Beta

0.24

52 Week Low

0.13

52 Week High

4.55

SMA50

2.88

SMA200

1.88

1 Week

+263.14%

1 Month

-80.37%

3 Month

-67.00%

6 Month

-67.00%

1 Year

-63.08%

2 Year

-59.39%

5 Year

-72.36%

Profile

cortexyme is developing therapeutics based on data supporting a new theory of the cause of alzheimer's and other degenerative disorders. cortexyme is targeting a specific, undisclosed pathogen tied to neurodegeneration and beta amyloid production. the target has been validated in a number of animal models and cortexyme is currently moving a proprietary small molecule towards human clinical testing.

QNCX Stock Summary

Quince Therapeutics, Inc. Common Stock (NASDAQ:QNCX) stock price today is $0.5300, and today's volume is 1,486,127,690. QNCX is up 305.692% today. The 30 day average volume is 5,080,173. QNCX market cap is 29.40M with 55,681,490 shares outstanding.

.dark-mode .cfVjbD{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .cfVjbD{ color: #333333; background-color: white; border: 2px solid #333333; }QNCXQuince Therapeutics, Inc. Common Stockstock NASDAQ

QNCX Stock Summary

QNCX
Quince Therapeutics, Inc. Common Stock
stock NASDAQ